Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54M
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
50.6M
-
Shares change
-
-574K
-
Total reported value, excl. options
-
$368M
-
Value change
-
-$5.89M
-
Put/Call ratio
-
0.07
-
Number of buys
-
68
-
Number of sells
-
-38
-
Price
-
$7.28
Significant Holders of Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) as of Q4 2022
128 filings reported holding FULC - Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2022.
Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.6M shares
of 54M outstanding shares and own 93.65% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (9.51M shares), FMR LLC (5.23M shares), RTW INVESTMENTS, LP (4.99M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (4.27M shares), BlackRock Inc. (3.27M shares), TRV GP IV, LLC (2.34M shares), VANGUARD GROUP INC (2.12M shares), Logos Global Management LP (2M shares), TRV GP III, LLC (1.96M shares), and COWEN AND COMPANY, LLC (1.36M shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.